These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2570153)

  • 1. Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists.
    Cannon JG; True CD; Long JP; Bhatnagar RK; Leonard P; Flynn JR
    J Med Chem; 1989 Sep; 32(9):2210-4. PubMed ID: 2570153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a potential dopaminergic prodrug moiety in several ring systems.
    Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK
    J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivatives of 5-hydroxy-6-methyl-2-aminotetralin.
    Cannon JG; Koble DL; Long JP; Verimer T
    J Med Chem; 1980 Jul; 23(7):750-4. PubMed ID: 6249931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions.
    Cannon JG; Brubaker AN; Long JP; Flynn JR; Verimer T; Harnirattisai P; Costall B; Naylor RJ; Nohria V
    J Med Chem; 1981 Feb; 24(2):149-53. PubMed ID: 7205882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible biologically active metabolites of 5-hydroxy-6-methyl-2-di-n-propylaminotetralin.
    Cannon JG; Furlano DC; Koble DL; Koons JC; Long JP
    Life Sci; 1984 Apr; 34(17):1679-82. PubMed ID: 6427543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 8. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211).
    Ma SX; Long JP; Flynn JR; Leonard PA; Cannon JG
    J Pharmacol Exp Ther; 1991 Feb; 256(2):751-6. PubMed ID: 1671601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 14. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins.
    DeMarinis RM; Shah DH; Hall RF; Hieble JP; Pendleton RG
    J Med Chem; 1982 Feb; 25(2):136-41. PubMed ID: 6120238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives.
    Verimer T; Long JP; Bhatnagar RK; Koble DL; Cannon JG; Flynn JR; Goodale DB; Arnerić SP
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):221-41. PubMed ID: 6791601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
    J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activity of a nonhydroxylated aminotetralin derivative (TL-68) on cat hearts.
    Ilhan M; Long JP; Cannon JG
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):213-9. PubMed ID: 6508433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.
    Venhuis BJ; Dijkstra D; Wustrow D; Meltzer LT; Wise LD; Johnson SJ; Wikström HV
    J Med Chem; 2003 Sep; 46(19):4136-40. PubMed ID: 12954065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-(Aminomethyl)-6,7-dihydroxytetralin derivatives: synthesis and assessment of dopamine-like effects.
    Cannon JG; Perez Z; Long JP; Ilhan M
    J Med Chem; 1983 Jun; 26(6):813-6. PubMed ID: 6854584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.